JPRN-UMIN000010408已完成未知
Efficacy of donepezil in Alzheimer's disease combined with cerebrovascular disease - Donepezil in Alzheimer's disease combined with cerebrovascular disease
Department of Neurology, Keio University,0 个研究点目标入组 460 人开始时间: 2013年4月7日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 460
研究概览
简要总结
The entry of the study cooperator was difficult within research period.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 65years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •other dementia
研究者
相似试验
已完成
1 期
Prediction of Cognitive Properties of New Drug Candidates for Neurodegenerative Diseases in Early Clinical DevelopmentAlzheimer DiseaseBatteryNCT01487395University Hospital, Lille30
已完成
4 期
Alzheimer's Disease Long-term Follow-up Study (ALF Study)Alzheimer's DiseaseNCT00165724Eisai Korea Inc.114
已完成
4 期
Hippocampus Study: Comparative Effect of Donepezil 10mg/d and Placebo on Clinical and Radiological MarkersAlzheimer's DiseaseNCT00403520Eisai Inc.240
已完成
不适用
Clinical Trial of Donepezil Between the Patients With Alzheimer's Disease and Mixed DementiaDementiaAlzheimer's DiseaseNCT01023867Samsung Medical Center88
已完成
不适用
Safety and Efficacy analysis of 10 mg donepezil for severe Alzheimer's disease: switch from the other cholineseterase inhibitorss diseaseAlzheimer's diseaseJPRN-UMIN000008971epartment of Neurology, Juntendo University School of Medicine50